Cancer Cell Reprogramming: Impact on Carcinogenesis and Cancer Progression

120.3K

views

191

authors

26

articles

Editorial

15 February 2023

Editorial: Cancer cell reprogramming: Impact on carcinogenesis and cancer progression

Yue Zhao

,

Simona Kranjc Brezar

,

Elvira V. Grigorieva

and

Ira-ida Skvortsova

1,958 views

1 citations

Editors

4

Ira Ida Skvortsova

Innsbruck Medical University

Elvira V Grigorieva

Institute of Molecular Biology and Biophysics FRC FTM

Simona Kranjc Brezar

Senior Research Associate, Institute of Oncology Ljubljana, Department of Experimental Oncology

Yue Zhao

University of Cologne

Impact

Fetching...

About

Various aspects related to carcinogenesis and cancer progression should comprehensively be investigated. It is believed that deep knowledge about malignant reprogramming can help to either prevent tumor development or to find an effective therapeutic target to combat disease progression. Since molecular and biological features of cancer cells are not similar at early and late tumor stages, different molecules and pathways should be targeted in cancer patients with early and advanced malignant disorders in order to reach a better clinical outcome.

A number of intra- and extracellular factors are already described to be implicated in cancer cell reprogramming. Among them, epigenetic factors, genetic mutations, intracellular pro-malignant, and pro-survival signaling pathways, etc. Additionally, a variety of microenvironmental factors should also be foreseen to be involved in the formation of carcinoma cells of different aggressiveness and sensitivities to currently used therapeutic approaches. Thus, hypoxia and non-malignant cells comprising the tumor (stroma cells, immune cells, etc.) could also modify the physiological and molecular properties of carcinoma cells and affect their sensitivities to treatment.

In this Research Topic, we aim to analyze and highlight the variety of factors associated with cancer cell reprogramming. It is proposed that the following aspects of the subject area will be discussed:
- Cancer cell reprogramming and cancer stem cells (CSCs);
- Tumor microenvironment and cancer cell reprogramming;
- Differentiation/dedifferentiation in CSCs;
- Therapy-induced cancer cell reprogramming;
- Alterations in molecular profiling during cancer progression and metastatic spread;
- Epigenetic factors contributing to cancer cell reprogramming;
- Regulation of immune response during cancer cell reprogramming

Download ebook

PDF

EPUB

Share

Editors

Ira Ida Skvortsova

Innsbruck Medical University

Elvira V Grigorieva

Institute of Molecular Biology and Biophysics FRC FTM

Simona Kranjc Brezar

Senior Research Associate, Institute of Oncology Ljubljana, Department of Experimental Oncology

Yue Zhao

University of Cologne

Impact

120,329 Total views

79,117 Article views

39,904 Article downloads

1,308 Topic views

Published In

Frontiers in Oncology

Molecular and Cellular Oncology

Frontiers in Cell and Developmental Biology

Molecular and Cellular Oncology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic